400 Summit Drive
33 articles with MilliporeSigma
MilliporeSigma celebrated the topping-out ceremony for its new membrane production plant in Darmstadt, Germany.
MilliporeSigma opened its M Lab™ Collaboration Center in Shanghai, the company's largest of nine centers worldwide.
MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19
Company will focus on process development and improvements for manufacturing Baylor's Covid-19 vaccine candidates
MilliporeSigma, a leader in genome editing, announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States.
MilliporeSigma, a leader in genome editing, announced that the United States Patent and Trademark Office has granted the company's patent for CRISPR-chrom technology.
First-to-market digital laboratory informatics solution with RFID labels for rapid access to reagent data - Improves inventory management; facilitates regulatory compliance; minimizes reagent waste - Reduces time on repetitive, error-prone tasks BURLINGTON, Mass. , March 3, 2020 /PRNewswire/ -- MilliporeSigma today launched its LANEXO™ Lab Inventory, Safety
Promega Corporation Enters License Agreement with MilliporeSigma to Access Foundational CRISPR Integration Technology
Scientists will have new view into natural cell activity, accelerating drug development
Gives scientists a new view into natural cell activity, accelerating drug development
MilliporeSigma announced it has received a prestigious R&D 100 Award for its Eshmuno® CP-FT resin, a first-to-market product used in biopharmaceutical manufacturing.
MilliporeSigma developed a new filtration-based manufacturing process resulting in a new, highly purified sucrose grade with reduced levels of nanoparticle impurities
MilliporeSigma Introduces Parteck® COAT Excipient, a Fast-Dissolving Material for Immediate Release Coating
MilliporeSigma has launched its Parteck® COAT excipient, a new functional material designed for immediate release film coating applications.
MilliporeSigma Launches ADC ExpressTM Services to Accelerate Pre-clinical Conjugation Candidate Selection
MilliporeSigma introduced its ADC Express TM services for the rapid production of ADCs, which can reduce the time needed to produce development grade constructs for target molecule identification.
MilliporeSigma to Launch ADC Express™ Services to Accelerate Pre-clinical Conjugation Candidate Selection
MilliporeSigma will launch its ADC Express™ services, which provide rapid production of ADCs for best candidate selection.
New framework simplifies and accelerates access to CRISPR intellectual property for research
MilliporeSigma Awards Grants to Biotechs Focused on Traumatic Brain Injury, Vaccine Development and Chronic Pain
MilliporeSigma, a leading science and technology company, today announced the winners of its Advance Biotech Grant program in North America during its Biotech Start-up Summit at the Cambridge Innovation Center.
To help scientists, researchers and manufacturers reduce their environmental footprint, MilliporeSigma expanded its DOZN™ system — an industry-first quantitative green chemistry tool that evaluates the relative greenness of chemicals and chemical processes against the 12 Principles of Green Chemistry.
• IP-protected compound is protected against generics • Directly bioavailable, easier for the body to metabolize • L-5-Methyltetrahydrofolate with unique counterion offers superior solubility, long-term stability
AISF was developed through a research collaboration with Pfizer Inc.
BioReliance® Viral and Gene Therapy Assay Portfolio wins award in Analytical/Test category
Twelve student finalists awarded in three fields: bioseparations, food & beverage safety and tumor biology